Medical marijuana study

On Thursday, Tilray Medical, a division of medical marijuana giant Tilray Brands, Inc. (NASDAQ:TLRY), announced the final results of a new scientific study, “Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV).” Results showed that cannabis...

A new study undertaken by Ireland's Health Research Board (HRB) showed evidence that medical marijuana can be used as a treatment for various conditions. The research was conducted to provide data to a Department of Health, which reviews the existing Medicinal Cannabis Access Programme (MCap) that...